Novozymes A-S (B) Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

53,52 EUR +2,20 EUR +4,29 %

13.02.2026

BMN

53,52 EUR +2,32 EUR +4,53 %

13.02.2026

GVIE

Novozymes A-S (B) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.24,12 Mrd. EUR

KGV81,80Div. Rendite1,52%

WKNA1JP9Y

ISINDK0060336014

SymbolNVZMF

Novozymes A-S (B) Aktien News

Sortieren:Datum Meistgelesen

26.04.23GlobeNewswireInterim report for Q1 2023

30.03.23GlobeNewswireNovozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

30.03.23GlobeNewswireResolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023

30.03.23GlobeNewswireCombination between Novozymes and Chr. Hansen approved by the Novozymes shareholders

28.03.23GlobeNewswireUpdate on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

23.03.23GlobeNewswireTrading by management and close relations of management

20.03.23GlobeNewswireTrading by management and close relations of management

17.03.23GlobeNewswireTrading by management and close relations of management

16.03.23GlobeNewswireTrading by management and close relations of management

15.03.23GlobeNewswireTrading by management and close relations of management

14.03.23GlobeNewswireTrading by management and close relations of management

13.03.23GlobeNewswireTrading by management and close relations of management

10.03.23GlobeNewswireTrading by management and close relations of management

08.03.23GlobeNewswireTrading by management and close relations of management

08.03.23GlobeNewswireInvitation to an extraordinary shareholders’ meeting of Novozymes A/S

08.03.23GlobeNewswirePublication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combin

07.03.23GlobeNewswireTrading by management and close relations of management

06.03.23GlobeNewswireTrading by management and close relations of management

03.03.23GlobeNewswireTrading by management and close relations of management

02.03.23GlobeNewswireResolutions from Novozymes A/S’ Annual Shareholders’ Meeting 2023

02.03.23GlobeNewswireTrading by management and close relations of management

01.03.23GlobeNewswireTrading by management and close relations of management

28.02.23GlobeNewswireTrading by management and close relations of management

27.02.23GlobeNewswireTrading by management and close relations of management

23.02.23GlobeNewswireTrading by management and close relations of management

22.02.23GlobeNewswireTrading by management and close relations of management

21.02.23GlobeNewswireTrading by management and close relations of management

18.02.23GlobeNewswireTrading by management and close relations of management

17.02.23GlobeNewswireTrading by management and close relations of management

16.02.23GlobeNewswireTrading by management and close relations of management

15.02.23GlobeNewswireTrading by management and close relations of management

14.02.23GlobeNewswireTrading by management and close relations of management

Novozymes A-S (B) News

Novozymes A-S (B) News: auf dieser Seite finden Sie alle Novozymes A-S (B) News und Nachrichten zur Novozymes A-S (B) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novozymes A-S (B) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novozymes A-S (B) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.